Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Cancer Research|May 15, 1998
Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analoguesM Binaschi, R Farinosi, C A Austin, et al.Cancer Chemotherapy and Pharmacology|January 1, 1997
Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeastE L Meczes, K L Marsh, L M Fisher, et al.Biochemical Pharmacology|June 1, 1988
The effect of terpenoid compounds on cytochrome P-450 levels in rat liverC A Austin, E A Shephard, S F Pike, et al.Age and Ageing|July 1, 1995
Xamoterol improves the control of chronic atrial fibrillation in elderly patientsP J Lawson-Matthew, K A McLean, M Dent, et al.Biochimica Et Biophysica Acta|March 30, 1999
Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplicationJ H Sng, V J Heaton, M Bell, et al.Molecular Pharmacology|December 1, 1996
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180)M Cornarotti, S Tinelli, E Willmore, et al.Biochemistry|February 24, 2000
Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passageK L West, E L Meczes, R Thorn, et al.Disability and Rehabilitation|May 23, 2002
Fear of falling, falls efficacy, and health outcomes in older people following hip fractureK J McKee, S Orbell, C A Austin, et al.Bone Marrow Transplantation|September 1, 1994
Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHDM H Cooper, K D Patrene, F Vecchini, et al.The Journal of Biological Chemistry|November 22, 1996
Threonine 1342 in human topoisomerase IIalpha is phosphorylated throughout the cell cycleR Ishida, M Iwai, K L Marsh, et al.Pageof 6